일시: 2024.10.12 (토)
장소: 서울대병원 윤덕병홀
| 08:55-09:00 | Opening Remark | 장병국 (지방간연구회 회장) |
| 09:00-09:05 | Welcoming Remark | 권영오 (대한간학회 회장) |
| 09:05-09:10 | Congratulatory Remark | 김윤준 (대한간학회 이사장) |
| Session 1. How can we utilize patient-derived samples in SLD research? | 좌장: 권영오 (경북의대) 박상훈 (한림의대) |
|
| 09:10-09:30 | Blood-based miRNA/protein biomarkers for prediction of at-risk MASH | 이영선 (고려의대) |
| 09:30-09:50 | Pathogenesis and treatment strategies of MASLD focusing on hepatocytes | 정영미 (부산대 자연과학대) |
| 09:50-10:10 | Diagnosis and evaluation of MAFLD/MASLD according to Chinese guideline | Jian-Gao Fan (Shanghai Jiao Tong University, China) |
| 10:10-10:30 | Immunological Researches for Novel Target Discovery in MASLD | 성필수 (가톨릭의대) |
| 10:30-10:40 | Coffee Break | |
| Session 2. KSSG & ARPSG joint session: Identification of SLD: Metabolic Dysfunction vs. Alcohol | 좌장: 장병국 (계명의대) 김원 (서울의대) |
|
| 10:40-11:00 | History of the Nomenclature of SLD and Definition of MASLD | 진영주 (인하의대) |
| 11:00-11:20 | Pathogenesis of Steatohepatitis in Alcohol-related Liver Disease | 서원효 (이화여대 약대) |
| 11:20-11:40 | Management of Metabolic Dysfunction in SLD | 유정주 (순천향의대) |
| 11:40-12:00 | Risk Thresholds for Alcohol Consumption across SLD | 김정희 (한림의대) |
| 12:00-13:00 | Lunch | |
| Session 3. The Integration of Big Data and Artificial Intelligence in SLD | 좌장: 이진우 (인하의대) 이정일 (연세의대) |
|
| 13:00-13:20 | Application of Machine Learning to Identify Clinically Significant Stages in MASLD | Ju Dong Yang (Cedars-Sinai Medical Center, US) |
| 13:20-13:40 | Big Data Study Integrating Transient Elastography to Predict Liver-Related Outcomes in MASLD | 김승업 (연세의대) |
| 13:40-14:00 | Design and Interpretation of a Nationwide Population-Based Cohort Study in MASLD | 구보경 (서울의대) |
| 14:00-14:20 | Artificial Intelligence for Detecting and Quantifying Hepatic Steatosis in Imaging Study | 강태욱 (성균관의대) |
| 14:20-14:30 | Coffee Break | |
| Session 4. Advances in the Management of SLD | 좌장: 조용균 (성균관의대) 김형준 (중앙의대) |
|
| 14:30-14:50 | Nutritional Intervention and Prescription for MASLD | 허양임 (차의대) |
| 14:50-15:10 | Role of Endoscopic Bariatric and Metabolic Therapist on Obesity and MASLD | 이상표 (한양의대) |
| 15:10-15:30 | The Impact of Microbiome on SLD: a Potential Therapeutic Target | 유현주 (서울대 생활과학대) | 15:30-15:50 | New and Emerging Treatments for Metabolic Dysfunction-associated Steatohepatitis | 정승원 (순천향의대) |
| 15:50-16:00 | Closing Remark | 손 원 (지방간연구회 학술이사) |